CTi Biopharma Corp Price on January 2, 2025

CTICDelisted Stock  USD 9.09  0.00  0.00%   
If you're considering investing in CTi Stock, it is important to understand the factors that can impact its price. As of today, the current price of CTi Biopharma stands at 9.09, as last reported on the 4th of January, with the highest price reaching 9.09 and the lowest price hitting 9.09 during the day. We have found twenty-five technical indicators for CTi Biopharma Corp, which you can use to evaluate the volatility of the firm. Please confirm CTi Biopharma's Downside Deviation of 2.35, mean deviation of 3.53, and Risk Adjusted Performance of 0.1238 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
CTi Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CTIC
Based on monthly moving average CTi Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CTi Biopharma by adding CTi Biopharma to a well-diversified portfolio.

Related Headline

Verastem Headline on 2nd of January 2025

Verastem Oncology Announces FDA Acceptance and Priority Review of NDA for Avutometinib and Defactinib

CTi Biopharma Valuation on January 2, 2025

It is possible to determine the worth of CTi Biopharma on a given historical date. On January 2, 2025 CTi was worth 9.09 at the beginning of the trading date compared to the closed value of 9.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CTi Biopharma stock. Still, in general, we apply an absolute valuation method to find CTi Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CTi Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CTi Biopharma's related companies.
 Open High Low Close Volume
01/04/2025
  9.09    9.09    9.09    9.09    0.00  
Backtest CTi Biopharma  |  CTi Biopharma History  |  CTi Biopharma Valuation 
Open Value
9.09
9.09
Closing Value
9.09
Upside

CTi Biopharma Trading Date Momentum on January 2, 2025

CTi Biopharma Corp Fundamentals Correlations and Trends

By evaluating CTi Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CTi Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CTi financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About CTi Biopharma Stock history

CTi Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CTi is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CTi Biopharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CTi Biopharma stock prices may prove useful in developing a viable investing in CTi Biopharma
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. Cti Biopharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 121 people.

CTi Biopharma Stock Technical Analysis

CTi Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of CTi Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CTi Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

CTi Biopharma Period Price Range

Low
January 4, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

CTi Biopharma Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

CTi Biopharma January 4, 2025 Market Strength

Market strength indicators help investors to evaluate how CTi Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CTi Biopharma shares will generate the highest return on investment. By undertsting and applying CTi Biopharma stock market strength indicators, traders can identify CTi Biopharma Corp entry and exit signals to maximize returns

CTi Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for CTi Biopharma's price direction in advance. Along with the technical and fundamental analysis of CTi Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CTi to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in CTi Stock

If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum